Hudson Bay Capital Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-59,006
Closed -$1.51M 784
2024
Q1
$1.51M Sell
59,006
-50,166
-46% -$1.29M 0.01% 501
2023
Q4
$3.01M Buy
109,172
+92,797
+567% +$5.66M 0.02% 388
2023
Q3
$996K Buy
16,375
+1,375
+9% +$96.6K 0.01% 566
2023
Q2
$987K Hold
15,000
0.01% 598
2023
Q1
$954K Buy
15,000
+12,750
+567% +$1.46M 0.01% 595
2022
Q4
$311K Sell
2,250
-4,750
-68% -$669K ﹤0.01% 734
2022
Q3
$886K Buy
+7,000
New +$792K 0.01% 859
2020
Q4
Sell
-2,123
Closed -$1.48M 604
2020
Q3
$1.48M Sell
2,123
-579
-21% -$452K 0.02% 387
2020
Q2
$2.14M Sell
2,702
-386
-13% -$291K 0.04% 305
2020
Q1
$1.84M Buy
+3,088
New +$3.01M 0.05% 273
2019
Q3
Sell
-3,474
Closed -$5.72M 413
2019
Q2
$5.72M Buy
3,474
+2,316
+200% +$4.01M 0.13% 155
2019
Q1
$2.36M Buy
+1,158
New +$2.04M 0.03% 429
2018
Q4
Sell
-1,189
Closed -$2.25M 778
2018
Q3
$2.25M Buy
+1,189
New +$2.46M 0.03% 441

Other funds holding BLUE

Hudson Bay Capital Management's BLUE Position: Q2 2024 in Review

Hudson Bay Capital Management sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 59,006 shares — an estimated $1.51M sold.

Hudson Bay Capital Management first reported a position in BLUE in Q3 2018 and held it in 13 quarters. The position peaked at $5.72M in Q2 2019. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • Hudson Bay Capital Management reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 59,006 bluebird bio shares in Q2 2024, an estimated $1.51M.
  • Hudson Bay Capital Management first reported a position in bluebird bio in Q3 2018 and held it in 13 quarters.
  • Hudson Bay Capital Management's bluebird bio position peaked at $5.72M in Q2 2019.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on Hudson Bay Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.